Pharmacologic agents on cardiovascular mass, coronary dynamics and collagen in aged spontaneously hypertensive rats

Journal of Hypertension

Volumn 17, Issue 8, 1999, Pages 1209-1215

  Susic, Dinko ^a   Varagic, Jasmina ^a   Frohlich, Edward D ^a  

^a OCHSNER MEDICAL CENTER   (United States)

Author keywords

Aging; Angiotensin converting enzyme inhibitor enalapril; Calcium antagonist; Coronary hemodynamics; Felodipine; Hypertension; Myocardial collagen concentration

Indexed keywords

COLLAGEN; ENALAPRIL; FELODIPINE; HYDROXYPROLINE;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE THERAPY; AORTA; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY HEMODYNAMICS; CORONARY VASCULAR RESISTANCE; HEART LEFT VENTRICLE; HEART MUSCLE FIBROSIS; HEART RIGHT VENTRICLE; HEART VOLUME; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR RESISTANCE;

EID: 0032805243     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199917080-00022     Document Type: Article

References (34)

1. 1 Frohlich ED, Apstein C, Chobanian AV, Devereux RB, Dustan HP, Dzau V, et al. The heart in hypertension. N Engl J Med 1992; 327:998-1008.
2. 2 Susic D, Frohlich ED. Left ventricular hypertrophy: a pathophysiological and molecular biological perspective. Hypertension Res 1993; 16:163-167.
3. 3 Marcus ML, Doty DB, Hiratzka FL. Decreased coronary reserve. N Engl J Med 1982; 307:1362-1366.
4. 4 Wicker P, Tarazi RC. Coronary blood flow in left ventricular hypertrophy: a review of experimental data. Eur Heart J 1983; 3 (suppl A);111-118.
5. 5 Lakatta EG. Cardiovascular regulatory mechanisms in advanced age. Physiol Rev 1993; 73:413-467.
6. 6 Pfeffer MA, Frohlich ED. Hemodynamic and myocardial function in young and old normotensive and spontaneously hypertensive rats. Circ Res 1973; 32:28-38.
7. 7 Assayag P, Charlemagne D, De Leiris J, Boucher F, Valere PE, Lortet S, et al. Senescent heart compared with pressure overload-induced hypertrophy. Hypertension 1997; 29:15-21.
8. 8 Hachamovitch R, Wicker P, Capasso JM, Anversa P. Alterations of coronary blood flow and reserve with aging in Fischer 344 rats. Am J Physiol 1989; 256:H66-H37.
9. 9 Lakatta EG. Do hypertension and aging have similar effect on the myocardium? Circulation 1987; 75 (suppl 1):I69-I77.
10. 10 Vitullo JC, Penn MS, Rakusan K, Wicker P. Effects of hypertension and aging on coronary artenolar density. Hypertension 1993; 21:406-414.
11. 11 Frohlich ED: Hypertension in the elderly. Cardiovasc Risk Factors 1994; 4:127-132.
12. 12 Susic D, Nunez E, Hosoya K, Frohlich ED. Coronary hemodynamics in aging spontaneously hypertensive and normotensive Wistar-Kyoto rats. J Hypertens 1998; 16:231-237.
13. 13 Swynghedauw B, Delcayre C, Cheav SL, Calens-El Amrani F. Biological basis of diastolic dysfunction in the hypertensive heart. Eur Heart J 1992; 13 (suppl D):2-8.
14. 14 Fouad-Tarazi FM. Left ventricular diastolic function in hypertension. Curr Opin Cardiol 1994; 9:551-560.
15. 15 Topol EJ, Traill TA, Fortuin NJ. Hypertensive hypertrophic cardiomyopathy of the elderly. New Engl J Med 1985; 312:277-283.
16. 16 Frohlich ED, Horinaka S. Cardiac and aortic effects of angiotensin converting enzyme inhibitors. Hypertension 1991; 18 (suppl II):2-7.
17. 17 Frohlich ED, Sasaki O, Chien Y, Arita M. Changes in cardiovascular mass, left ventricular pumping ability, and aortic distensibility after calcium antagonists in Wistar-Kyoto and spontaneously hypertensive rats. J Hypertension 1992; 10:1369-1378.
18. 18 Pfeffer JM, Pfeffer MA, Fletcher PJ, Fishbein MC, Braunwald E. Favorable effects of therapy on cardiovascular performance in spontaneously hypertensive rats. Am J Physiol 1982; 242:H776-H784.
19. 19 Ruskoaho HJ, Savolainen ER. Effects of long term verapamil treatment on blood pressure, cardiac hypertrophy, and collagen metabolism In spontaneously hypertensive rats. Cardiovasc Res 1985; 19:355-362.
20. 20 Sato F, Isoyama S, Takishima T. Normalization of impaired coronary circulation in hypertrophied rat hearts. Hypertension 1990; 16:26-34.
21. 21 Ando K, Frohlich ED, Chien Y, Pegram BL. Effects of quinapril on systemic and regional hemodynamics and cardiac mass in spontaneously hypertensive and Wistar-Kyoto rats. J Vasc Med Biol 1991; 3:117-123.
22. 22 Clozel JP, Veniant M, Hess P, Sprecher U. Effects of two angiotensin converting enzyme inhibitors and hydralazine on coronary circulation in hypertensive rats. Hypertension 1991; 18 (suppl II):II8-II14.
23. 23 Nunez E, Hosoya K, Susic D, Frohlich ED. Enalapril and losartan reduced cardiac mass and improved coronary hemodynamics in SHR. Hypertension 1997; 29:519-524.
24. 24 Callens-El Amrani F, Cheaw SL, Chevalier B, Paolaggi F, Jouquey S, Hamon G, et al. Regression of left ventricular hypertrophy by converting enzyme inhibition in 12-15-month-old spontaneously hypertensive rats: effects on coronary resistance and ventricular compliance in normoxia and anoxia. J Cardiovasc Pharmacol 1994; 23:155-165.
25. 25 Ishise S, Pegram BL, Yamamoto J, Kitamura Y, Frohlich ED: Reference sample microsphere method: cardiac output and blood flows in conscious rat. Am J Physiol 1980; 239:H443-H449.
26. 26 Kobrin I, Kardon MB, Oigman W, Pegram BL, Frohlich ED. Role of site of microsphere injection and catheter position on systemic and regional hemodynamics in rat. Am J Physiol 1984; 247:H35-H39.
27. 27 Kaneko K, Susic D, Nunez E, Frohlich ED. Losartan reduces cardiac mass and improves coronary flow reserve in the spontaneously hypertensive rat. J Hypertens 1996; 14:645-653.
28. 28 Tomanek RJ, Wrangler RD, Bauer CA. Prevention of coronary vasodilator reserve decrement in spontaneously hypertensive rats. Hypertension 1985; 7:533-540.
29. 29 Sesoko S, Pogram BL, Kuwajima I, Frohlich ED. Hemodynamic studies in spontaneously hypertensive rats with congenital arteriovenous shunts. Am J Physiol 1982; 242:H722-H725.
30. 30 Armitago P, Berry G: Statistical methods in medical research, 3rd edn. Oxford: Blackwell Scientific Publications; 1994.
31. 31 Arita M, Horinaka S, Frohlich ED. Biochemical components and myocardial performance after reversal of left ventricular hypertrophy in spontaneously hypertensive rats. J Hypertens 1993; 11:951-959.
32. 32 Arita M, Horinaka S, Komatsu K, Frohlich ED. Reversal of left ventricular hypertrophy with different classes of drugs causes differing ventricular biochemical changes. J Hypertens 1993; 11:S354-S355.
33. 33 Aristizabal D, Messerli FH, Frohlich ED. Disparate structural effects on left and right ventricles by angiotensin converting enzyme inhibitors and calcium antagonists. Am J Cardiol 1994; 73:483-487.
34. 34 Brilla CG, Janicki JS, Weber KT. Impaired diastolic function and coronary reserve in genetic hypertension. Role of interstitial fibrosis and medial thickening of intra-myocardial coronary arteries. Circ Res 1991; 69:107-115.